Guggenheim Active Allocation Fund (GUG) Competitors $15.53 +0.16 (+1.04%) Closing price 08/7/2025 03:59 PM EasternExtended Trading$15.52 -0.01 (-0.06%) As of 08/7/2025 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsDividendHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock GUG vs. ABLLL, ASGI, AFJKR, ATMCR, ARBKL, ATLCL, ATCOL, RILYN, RILYG, and RILYZShould you be buying Guggenheim Active Allocation Fund stock or one of its competitors? The main competitors of Guggenheim Active Allocation Fund include Abacus Life, Inc. 9.875% Fixed Rate Senior Notes due 2028 (ABLLL), Abrdn Global Infrastructure Income Fund (ASGI), Aimei Health Technology (AFJKR), AlphaTime Acquisition (ATMCR), Argo Blockchain plc 8.75% Senior Notes due 2026 (ARBKL), Atlanticus Holdings Co. 6.125% Senior Notes due 2026 (ATLCL), Atlas (ATCOL), B. Riley Financial, Inc. - 6.50 (RILYN), B. Riley Financial, Inc. 5.00% Senior Notes due 2026 (RILYG), and B. Riley Financial, Inc. 5.25% Senior Notes due 2028 (RILYZ). These companies are all part of the "-" industry. Guggenheim Active Allocation Fund vs. Its Competitors Abacus Life, Inc. 9.875% Fixed Rate Senior Notes due 2028 Abrdn Global Infrastructure Income Fund Aimei Health Technology AlphaTime Acquisition Argo Blockchain plc 8.75% Senior Notes due 2026 Atlanticus Holdings Co. 6.125% Senior Notes due 2026 Atlas B. Riley Financial, Inc. - 6.50 B. Riley Financial, Inc. 5.00% Senior Notes due 2026 B. Riley Financial, Inc. 5.25% Senior Notes due 2028 Guggenheim Active Allocation Fund (NYSE:GUG) and Abacus Life, Inc. 9.875% Fixed Rate Senior Notes due 2028 (NASDAQ:ABLLL) are both - industry companies, but which is the better stock? We will compare the two businesses based on the strength of their media sentiment, valuation, profitability, dividends, analyst recommendations, risk, earnings and institutional ownership. Which has stronger earnings and valuation, GUG or ABLLL? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioGuggenheim Active Allocation Fund$46.97MN/AN/AN/AN/AAbacus Life, Inc. 9.875% Fixed Rate Senior Notes due 2028$134.58MN/AN/AN/AN/A Does the media refer more to GUG or ABLLL? In the previous week, Guggenheim Active Allocation Fund and Guggenheim Active Allocation Fund both had 1 articles in the media. Guggenheim Active Allocation Fund's average media sentiment score of 1.00 equaled Abacus Life, Inc. 9.875% Fixed Rate Senior Notes due 2028'saverage media sentiment score. Company Overall Sentiment Guggenheim Active Allocation Fund Positive Abacus Life, Inc. 9.875% Fixed Rate Senior Notes due 2028 Positive Is GUG or ABLLL more profitable? Company Net Margins Return on Equity Return on Assets Guggenheim Active Allocation FundN/A N/A N/A Abacus Life, Inc. 9.875% Fixed Rate Senior Notes due 2028 N/A N/A N/A SummaryAbacus Life, Inc. 9.875% Fixed Rate Senior Notes due 2028 beats Guggenheim Active Allocation Fund on 1 of the 1 factors compared between the two stocks. Get Guggenheim Active Allocation Fund News Delivered to You Automatically Sign up to receive the latest news and ratings for GUG and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding GUG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart GUG vs. The Competition Export to ExcelMetricGuggenheim Active Allocation Fund- Industry SectorNYSE ExchangeMarket CapN/A$1.43M$2.03B$20.70BDividend Yield9.79%8.95%13.67%3.67%P/E RatioN/AN/A12.2828.64Price / SalesN/AN/A2,676,059.9557.35Price / CashN/AN/A57.4723.59Price / BookN/AN/A3.104.32Net IncomeN/AN/A-$461.08M$995.66M7 Day Performance1.77%0.29%0.91%1.91%1 Month Performance0.26%3.18%0.94%-0.54%1 Year Performance0.32%5.81%10.18%14.76% Guggenheim Active Allocation Fund Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)GUGGuggenheim Active Allocation FundN/A$15.53+1.0%N/A+1.1%$0.00$46.97M0.00N/APositive NewsDividend AnnouncementABLLLAbacus Life, Inc. 9.875% Fixed Rate Senior Notes due 2028N/A$24.960.0%N/A-1.4%$0.00$134.58M0.00N/APositive NewsUpcoming EarningsDividend AnnouncementASGIAbrdn Global Infrastructure Income FundN/A$21.24+0.8%N/A+16.0%$0.00$48.76M0.00N/AAFJKRAimei Health TechnologyN/A$0.32-8.6%N/AN/A$0.00N/A0.00N/APositive NewsGap DownATMCRAlphaTime AcquisitionN/A$0.25-2.4%N/AN/A$0.00N/A0.002Positive NewsGap UpARBKLArgo Blockchain plc 8.75% Senior Notes due 2026N/A$2.91-0.7%N/A-72.6%$0.00N/A0.0048Positive NewsGap UpATLCLAtlanticus Holdings Co. 6.125% Senior Notes due 2026N/A$24.49+0.2%N/A+10.6%$0.00N/A0.00357Positive NewsATCOLAtlasN/A$25.33+0.0%N/A+1.3%$0.00N/A0.006,200High Trading VolumeRILYNB. Riley Financial, Inc. - 6.50N/A$18.500.0%N/A+5.7%$0.00N/A0.002,210Positive NewsRILYGB. Riley Financial, Inc. 5.00% Senior Notes due 2026N/A$17.38+1.6%N/A+7.8%$0.00N/A0.00574High Trading VolumeRILYZB. Riley Financial, Inc. 5.25% Senior Notes due 2028N/A$11.31+7.5%N/A-15.0%$0.00N/A0.00574Positive News Related Companies and Tools Related Companies ABLLL Competitors ASGI Competitors AFJKR Competitors ATMCR Competitors ARBKL Competitors ATLCL Competitors ATCOL Competitors RILYN Competitors RILYG Competitors RILYZ Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:GUG) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredProtect Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredSell this, buy thatWhat you don’t own matters just as much as what you do. That’s the thinking behind Eric Fry’s long-time strate...InvestorPlace | SponsoredAmazon’s big Bitcoin embarrassmentBitcoin just passed Amazon in total market cap — but most investors are missing the bigger opportunity. Whi...Brownstone Research | SponsoredAltucher: Trump’s Great Gain is startingNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredCritical AI announcement set to ignite AI 2.0 A new 100% tariff on imported chips just rattled the tech sector—sending some stocks soaring and others tumbli...Timothy Sykes | SponsoredTrump’s new nightmareAccording to Porter Stansberry and Jeff Brown, a government-led financial mobilization is already reshaping Am...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Guggenheim Active Allocation Fund Please log in to your account or sign up in order to add this asset to your watchlist. Share Guggenheim Active Allocation Fund With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.